Healthcare & Life Sciences

Metabomed

France

series-a

Stage

Investors

About

Metabomed is a biotechnology company focused on discovering cancer drugs by targeting metabolic vulnerabilities specific to tumor cells.

Funding rounds, investor list, and risk signals — unlock with a subscription.